| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF21B MAP7D3 CALD1 MARK1 SYNE1 KTN1 CEP290 NUMA1 CKAP5 HOOK1 MICALL2 ANKRD1 TUBGCP3 LIMCH1 CACYBP PLEKHH2 SCIN | 4.46e-05 | 1099 | 103 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 5.80e-05 | 15 | 103 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | helicase activity | 1.70e-04 | 158 | 103 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.19e-04 | 262 | 103 | 7 | GO:0140097 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF21B ENKUR MAP7D3 ATRX MARK1 IFT172 KTN1 CEP290 NUMA1 CKAP5 DICER1 CATSPER1 SUGT1 HOOK1 CCDC42 TUBGCP3 TTL | 1.83e-05 | 1058 | 103 | 17 | GO:0007017 |
| GeneOntologyCellularComponent | sperm principal piece | 6.99e-05 | 44 | 105 | 4 | GO:0097228 | |
| Domain | SGS | 2.90e-05 | 2 | 101 | 2 | PS51048 | |
| Domain | SGS | 2.90e-05 | 2 | 101 | 2 | PF05002 | |
| Domain | SGS_dom | 2.90e-05 | 2 | 101 | 2 | IPR007699 | |
| Domain | ADD | 1.73e-04 | 4 | 101 | 2 | IPR025766 | |
| Domain | ADD | 1.73e-04 | 4 | 101 | 2 | PS51533 | |
| Domain | Helicase_C | 2.88e-04 | 107 | 101 | 5 | PF00271 | |
| Domain | HELICc | 2.88e-04 | 107 | 101 | 5 | SM00490 | |
| Domain | Helicase_C | 3.00e-04 | 108 | 101 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 3.13e-04 | 109 | 101 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.13e-04 | 109 | 101 | 5 | PS51192 | |
| Domain | DEXDc | 3.13e-04 | 109 | 101 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.27e-04 | 110 | 101 | 5 | IPR014001 | |
| Domain | SNF2_N | 6.79e-04 | 32 | 101 | 3 | IPR000330 | |
| Domain | SNF2_N | 6.79e-04 | 32 | 101 | 3 | PF00176 | |
| Pubmed | RANBP2 ELOA2 CALD1 ATRX SYNE1 KTN1 NUMA1 DNAJC18 CHD2 CTAGE6 RYR2 ACSM3 HOOK1 FAM50A TNN ITSN2 DLAT LIMCH1 MPHOSPH10 CTAGE4 ATP2A2 THRAP3 DOP1A DNMT3B | 1.54e-11 | 1442 | 109 | 24 | 35575683 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RANBP2 EDF1 CDV3 SERBP1 MAP7D3 CALD1 POLA1 KTN1 CKAP5 RUVBL2 CDC42BPB DICER1 FAM50A MPHOSPH10 CACYBP ATP2A2 THRAP3 | 1.18e-10 | 724 | 109 | 17 | 36232890 |
| Pubmed | RANBP2 EDF1 SERBP1 ATRX DNAJC8 SYNE1 PARP2 KTN1 INTS1 CKAP5 APLP2 CHD2 CDC42BPB DICER1 MICALL2 ITSN2 HLTF LIMCH1 MPHOSPH10 SGF29 MRPL49 ATP2A2 | 1.27e-09 | 1497 | 109 | 22 | 31527615 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RANBP2 SERBP1 ATRX DNAJC8 POLA1 SYNE1 KTN1 NUMA1 CKAP5 APLP2 PSMD12 RUVBL2 DICER1 DDX54 DLAT GALNT5 CACYBP ATP2A2 THRAP3 SNX2 GOLGA4 | 3.06e-09 | 1425 | 109 | 21 | 30948266 |
| Pubmed | ATRX DNAJC8 SYNE1 KTN1 DNAJC18 CDC42BPB DICER1 FAM171A1 PASK SENP1 SUGT1 NDUFAF1 TUBGCP3 DDX54 DLAT SDF4 CACYBP MRPL49 ATP2A2 SNX2 GOLGA4 | 6.44e-09 | 1487 | 109 | 21 | 33957083 | |
| Pubmed | RANBP2 EDF1 CDV3 SERBP1 CALD1 KTN1 NUMA1 CKAP5 VPS13D SUGT1 LIMCH1 SNX2 GOLGA4 | 2.87e-08 | 568 | 109 | 13 | 37774976 | |
| Pubmed | RANBP2 SERBP1 MAP7D3 CALD1 DNAJC8 KTN1 NUMA1 CKAP5 PSMD12 RUVBL2 FAM171A1 CACYBP ATP2A2 GOLGA4 | 4.99e-08 | 708 | 109 | 14 | 39231216 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANBP2 EDF1 CDV3 SERBP1 MAP7D3 CALD1 CEP290 CKAP5 RUVBL2 SENP1 SH2D4A SUGT1 HOOK1 ITSN2 SNX2 | 7.39e-08 | 853 | 109 | 15 | 28718761 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RANBP2 MAP7D3 ATRX PARP2 KTN1 CEP290 INTS1 NUMA1 CKAP5 CHD2 SP110 RUVBL2 DDX54 HLTF ZCCHC7 SGF29 ATP2A2 THRAP3 | 1.12e-07 | 1294 | 109 | 18 | 30804502 |
| Pubmed | RANBP2 SERBP1 POLA1 INTS1 NUMA1 CKAP5 CHD2 PSMD12 DICER1 DDX54 DLAT MPHOSPH10 ATP2A2 | 1.44e-07 | 653 | 109 | 13 | 22586326 | |
| Pubmed | CDV3 SERBP1 MAP7D3 CALD1 DNAJC8 KTN1 NUMA1 RUVBL2 SUGT1 CACYBP THRAP3 SNX2 | 1.66e-07 | 549 | 109 | 12 | 38280479 | |
| Pubmed | RANBP2 CEP290 APLP2 PSMD12 CDC42BPB FAM171A1 CADM1 SH2D4A SUGT1 DDX54 SDF4 CACYBP MAPK9 SCIN ATP2A2 GOLGA4 | 1.81e-07 | 1049 | 109 | 16 | 27880917 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RANBP2 EDF1 CDV3 SERBP1 POLA1 KTN1 NUMA1 CKAP5 RUVBL2 FAM50A DDX54 HLTF DLAT CACYBP MRPL49 ATP2A2 THRAP3 GOLGA4 | 4.16e-07 | 1415 | 109 | 18 | 28515276 |
| Pubmed | 4.31e-07 | 216 | 109 | 8 | 31519766 | ||
| Pubmed | RANBP2 SERBP1 ACADL MARK1 KTN1 CKAP5 PSMD12 RUVBL2 CDC42BPB RYR2 FABP7 SUGT1 DLAT CACYBP ATP2A2 THRAP3 | 5.41e-07 | 1139 | 109 | 16 | 36417873 | |
| Pubmed | EDF1 SERBP1 DNAJC8 NUMA1 SUGT1 HOOK1 FAM50A CACYBP QKI THRAP3 | 5.49e-07 | 399 | 109 | 10 | 35987950 | |
| Pubmed | 1.33e-06 | 251 | 109 | 8 | 31076518 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANBP2 EDF1 CDV3 SERBP1 MAP7D3 CALD1 ATRX KTN1 NUMA1 CKAP5 SUGT1 FAM50A CACYBP SCIN | 1.39e-06 | 934 | 109 | 14 | 33916271 |
| Pubmed | CDV3 CALD1 POLA1 PARP2 CEP290 INTS1 PSMD12 QSOX1 GARIN3 SCAPER PLEKHH2 QKI | 1.81e-06 | 689 | 109 | 12 | 36543142 | |
| Pubmed | KIF21B RANBP2 ZNF618 SYNE1 KTN1 NUMA1 CKAP5 CDC42BPB FAM171A1 SENP1 HOOK1 LIMCH1 THRAP3 GOLGA4 | 1.98e-06 | 963 | 109 | 14 | 28671696 | |
| Pubmed | 2.12e-06 | 360 | 109 | 9 | 33111431 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RANBP2 ATRX INTS1 CKAP5 PSMD12 RUVBL2 SUGT1 TUBGCP3 HLTF THRAP3 SNX2 | 2.29e-06 | 582 | 109 | 11 | 20467437 |
| Pubmed | SERBP1 CALD1 ACADL MARK1 SYNE1 KTN1 CKAP5 NCAM2 ALDH1L1 CDC42BPB ITSN2 SCAPER DLAT LIMCH1 ATP2A2 THRAP3 SNX2 | 2.29e-06 | 1431 | 109 | 17 | 37142655 | |
| Pubmed | RANBP2 EDF1 SERBP1 CALD1 PARP2 KTN1 NUMA1 PSMD12 DICER1 SUGT1 DDX54 HLTF SDF4 LIMCH1 MRPL49 ATP2A2 THRAP3 | 2.49e-06 | 1440 | 109 | 17 | 30833792 | |
| Pubmed | RANBP2 CDV3 SERBP1 DNAJC8 KTN1 PSMD12 RUVBL2 QSOX1 DDX54 SGF29 ATP2A2 THRAP3 | 2.50e-06 | 711 | 109 | 12 | 33022573 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | KIF21B CDV3 SERBP1 CALD1 DNAJC8 NUMA1 CKAP5 PSMD12 RUVBL2 FAM50A SCAPER THRAP3 DOP1A | 2.63e-06 | 847 | 109 | 13 | 35235311 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RANBP2 SERBP1 CALD1 DNAJC8 SYNE1 NUMA1 CKAP5 RUVBL2 SH2D4A SUGT1 MICALL2 TUBGCP3 ITSN2 SGF29 THRAP3 | 3.31e-06 | 1155 | 109 | 15 | 20360068 |
| Pubmed | RANBP2 EDF1 SERBP1 ATRX DNAJC8 POLA1 INTS1 NUMA1 CHD2 RUVBL2 FAM50A HLTF CACYBP THRAP3 | 3.60e-06 | 1014 | 109 | 14 | 32416067 | |
| Pubmed | MARK1 ZNF618 KTN1 CEP290 CDC42BPB VPS13D SCAPER PLEKHH2 SCIN DOP1A | 3.64e-06 | 493 | 109 | 10 | 15368895 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANBP2 CALD1 SYNE1 CEP290 INTS1 NUMA1 CKAP5 RUVBL2 DICER1 DDX54 SCIN ATP2A2 THRAP3 SNX2 | 4.03e-06 | 1024 | 109 | 14 | 24711643 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 4.41e-06 | 394 | 109 | 9 | 27248496 | |
| Pubmed | SERBP1 DNAJC8 SYNE1 PSMD12 RUVBL2 SUGT1 HLTF LIMCH1 MPHOSPH10 GALNT5 CACYBP PLEKHH2 | 4.54e-06 | 754 | 109 | 12 | 35906200 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 POLA1 KTN1 NUMA1 CKAP5 CHD2 RUVBL2 SUGT1 TUBGCP3 DDX54 HLTF DLAT MRPL49 ATP2A2 THRAP3 GOLGA4 | 4.98e-06 | 1353 | 109 | 16 | 29467282 |
| Pubmed | RANBP2 POLA1 IFT172 CKAP5 PSMD12 RUVBL2 TUBGCP3 DLAT CACYBP ATP2A2 SNX2 | 5.49e-06 | 638 | 109 | 11 | 33239621 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RANBP2 ATRX NUMA1 CKAP5 QSOX1 PASK SH2D4A LIMCH1 ATP2A2 THRAP3 SNX2 GOLGA4 | 5.92e-06 | 774 | 109 | 12 | 15302935 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RANBP2 EDF1 MARK1 ZNF618 SYNE1 INTS1 APLP2 CHD2 RUVBL2 TUBGCP3 MRPL49 ATP2A2 THRAP3 DNMT3B | 7.53e-06 | 1082 | 109 | 14 | 38697112 |
| Pubmed | 7.84e-06 | 86 | 109 | 5 | 37253089 | ||
| Pubmed | RANBP2 EDF1 DNAJC8 CKAP5 PSMD12 RUVBL2 SUGT1 TUBGCP3 HLTF CACYBP QKI SGF29 ATP2A2 THRAP3 | 9.35e-06 | 1103 | 109 | 14 | 34189442 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RANBP2 EDF1 SERBP1 MAP7D3 CALD1 ATRX DNAJC8 KTN1 NUMA1 MPHOSPH10 ZCCHC7 ATP2A2 THRAP3 | 9.46e-06 | 954 | 109 | 13 | 36373674 |
| Pubmed | JNK2, a Newly-Identified SERCA2 Enhancer, Augments an Arrhythmic [Ca2+]SR Leak-Load Relationship. | 9.73e-06 | 2 | 109 | 2 | 33334123 | |
| Pubmed | SYNE1-QK1 SNPs, G × G and G × E interactions on the risk of hyperlipidaemia. | 9.73e-06 | 2 | 109 | 2 | 32281752 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20716843 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | CALD1 CEP290 FAM161B RUVBL2 PASK VPS13D SDF4 ATP2A2 THRAP3 GOLGA4 | 1.18e-05 | 564 | 109 | 10 | 21565611 |
| Pubmed | 1.21e-05 | 339 | 109 | 8 | 37232246 | ||
| Pubmed | 1.24e-05 | 340 | 109 | 8 | 24332808 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | SYNE1 INTS1 CKAP5 RUVBL2 CDC42BPB CADM1 SH2D4A SUGT1 NDUFAF1 ATP2A2 | 1.35e-05 | 573 | 109 | 10 | 28330616 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RANBP2 PARP2 INTS1 NUMA1 CHD2 PSMD12 RUVBL2 DDX54 HLTF MPHOSPH10 CACYBP MRPL49 ATP2A2 THRAP3 SNX2 | 1.59e-05 | 1318 | 109 | 15 | 30463901 |
| Pubmed | MLF2 Negatively Regulates P53 and Promotes Colorectal Carcinogenesis. | 1.60e-05 | 48 | 109 | 4 | 37438558 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.70e-05 | 256 | 109 | 7 | 33397691 | |
| Pubmed | KIF21B CDV3 SERBP1 ATRX POLA1 INTS1 APLP2 DICER1 KMT5B FAM50A DDX54 SCAPER DLAT SGF29 CRAMP1 | 1.72e-05 | 1327 | 109 | 15 | 32694731 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MAP7D3 SYNE1 KTN1 SLC25A25 VPS13D SENP1 SUGT1 NDUFAF1 ITSN2 DDX54 DLAT MPHOSPH10 CACYBP QKI MRPL49 ATP2A2 | 1.73e-05 | 1496 | 109 | 16 | 32877691 |
| Pubmed | RANBP2 SERBP1 MAP7D3 KTN1 CEP290 INTS1 CKAP5 APLP2 PSMD12 TUBGCP3 DDX54 HLTF SDF4 IL6ST | 1.77e-05 | 1168 | 109 | 14 | 19946888 | |
| Pubmed | 1.97e-05 | 17 | 109 | 3 | 37072811 | ||
| Pubmed | 2.34e-05 | 486 | 109 | 9 | 20936779 | ||
| Pubmed | Serological detection of cutaneous T-cell lymphoma-associated antigens. | 2.36e-05 | 18 | 109 | 3 | 11149944 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RANBP2 EDF1 CDV3 CALD1 KTN1 CKAP5 PSMD12 RUVBL2 CADM1 SUGT1 FAM50A CACYBP QKI ATP2A2 THRAP3 | 2.43e-05 | 1367 | 109 | 15 | 32687490 |
| Pubmed | EDF1 SERBP1 KTN1 NUMA1 CHD2 RUVBL2 CDC42BPB DICER1 FAM50A TUBGCP3 DLAT SDF4 LIMCH1 QKI THRAP3 | 2.51e-05 | 1371 | 109 | 15 | 36244648 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | SERBP1 MAP7D3 KTN1 NUMA1 CKAP5 RUVBL2 DDX54 SCAPER DLAT MPHOSPH10 SGF29 | 2.75e-05 | 759 | 109 | 11 | 35915203 |
| Pubmed | 2.75e-05 | 55 | 109 | 4 | 18570454 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.79e-05 | 497 | 109 | 9 | 36774506 | |
| Pubmed | Current view on cellular function of S100A6 and its ligands, CacyBP/SIP and Sgt1. | 2.91e-05 | 3 | 109 | 2 | 30656909 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 22679391 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 29986885 | ||
| Pubmed | T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation. | 2.91e-05 | 3 | 109 | 2 | 23091043 | |
| Pubmed | Rbm10 regulates inflammation development via alternative splicing of Dnmt3b. | 2.91e-05 | 3 | 109 | 2 | 29309623 | |
| Pubmed | 3.28e-05 | 20 | 109 | 3 | 33397958 | ||
| Pubmed | RANBP2 SERBP1 KTN1 NUMA1 PSMD12 RUVBL2 SUGT1 DDX54 DLAT LIMCH1 MPHOSPH10 CACYBP ATP2A2 THRAP3 | 3.62e-05 | 1247 | 109 | 14 | 27684187 | |
| Pubmed | SERBP1 CALD1 NUMA1 PSMD12 RUVBL2 DLAT CACYBP MRPL49 ATP2A2 THRAP3 SNX2 | 3.77e-05 | 786 | 109 | 11 | 29128334 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | SERBP1 MAP7D3 CALD1 SYNE1 PARP2 NUMA1 SENP1 DDX54 LIMCH1 MPHOSPH10 ATP2A2 THRAP3 | 4.41e-05 | 949 | 109 | 12 | 36574265 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.44e-05 | 123 | 109 | 5 | 26912792 | |
| Pubmed | 4.53e-05 | 408 | 109 | 8 | 33766124 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RANBP2 SERBP1 CKAP5 PSMD12 RUVBL2 DLAT CACYBP ATP2A2 THRAP3 SNX2 | 4.76e-05 | 665 | 109 | 10 | 30457570 |
| Pubmed | ZNF618 SCEL SP110 RUVBL2 DICER1 PASK SENP1 KMT5B TUBGCP3 SCAPER DLAT SDF4 SGF29 | 4.83e-05 | 1116 | 109 | 13 | 31753913 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RANBP2 SERBP1 ATRX PSMD12 RUVBL2 CDC42BPB PASK SH2D4A NDUFAF1 HOOK1 KMT5B CACYBP ATP2A2 THRAP3 | 4.97e-05 | 1284 | 109 | 14 | 17353931 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RANBP2 IFT172 CKAP5 APLP2 PSMD12 DICER1 PASK DDX54 CACYBP MAPK9 QKI SNX2 | 5.65e-05 | 974 | 109 | 12 | 28675297 |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 35750275 | ||
| Pubmed | Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. | 5.82e-05 | 4 | 109 | 2 | 19260764 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 22798524 | ||
| Pubmed | JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1. | 5.82e-05 | 4 | 109 | 2 | 25077544 | |
| Pubmed | MAP7D3 PSMD12 RUVBL2 DICER1 SUGT1 FAM50A LIMCH1 CACYBP ATP2A2 | 5.84e-05 | 547 | 109 | 9 | 37267103 | |
| Pubmed | CRISPR/Cas9-mediated Genomic Editing of Cluap1/IFT38 Reveals a New Role in Actin Arrangement. | 5.89e-05 | 213 | 109 | 6 | 29615496 | |
| Pubmed | 6.44e-05 | 133 | 109 | 5 | 15144186 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RANBP2 CDV3 SERBP1 CALD1 CKAP5 PSMD12 RUVBL2 HOOK1 DLAT LIMCH1 CACYBP ATP2A2 SNX2 | 6.49e-05 | 1149 | 109 | 13 | 35446349 |
| Pubmed | 6.55e-05 | 25 | 109 | 3 | 38877142 | ||
| Pubmed | RANBP2 SERBP1 KTN1 NUMA1 RUVBL2 TUBGCP3 DDX54 MPHOSPH10 QKI ATP2A2 THRAP3 | 7.36e-05 | 847 | 109 | 11 | 35850772 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | RANBP2 EDF1 SERBP1 KTN1 CKAP5 ARHGAP30 RUVBL2 ITSN2 DDX54 CACYBP | 7.38e-05 | 701 | 109 | 10 | 30196744 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MARK1 POLA1 KTN1 PSMD12 DICER1 SUGT1 TUBGCP3 HLTF SDF4 CACYBP QKI SGF29 | 7.61e-05 | 1005 | 109 | 12 | 19615732 |
| Pubmed | TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | 7.67e-05 | 138 | 109 | 5 | 37506885 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 8.17e-05 | 226 | 109 | 6 | 37839992 | |
| Pubmed | 8.29e-05 | 27 | 109 | 3 | 20301537 | ||
| Pubmed | 8.46e-05 | 330 | 109 | 7 | 32529326 | ||
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 8.62e-05 | 331 | 109 | 7 | 19490893 | |
| Pubmed | 8.79e-05 | 332 | 109 | 7 | 37433992 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 8.95e-05 | 333 | 109 | 7 | 32665550 | |
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 34048572 | ||
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 33060591 | ||
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 25114248 | ||
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 27494721 | ||
| Pubmed | Calcyclin Binding Protein/Siah-1 Interacting Protein Is a Hsp90 Binding Chaperone. | 9.67e-05 | 5 | 109 | 2 | 27249023 | |
| Pubmed | Chromosome mapping of five human cardiac and skeletal muscle sarcoplasmic reticulum protein genes. | 9.67e-05 | 5 | 109 | 2 | 8406504 | |
| Interaction | KCNA3 interactions | RANBP2 SERBP1 MAP7D3 CALD1 DNAJC8 KTN1 NUMA1 CKAP5 CHD2 PSMD12 RUVBL2 FAM171A1 HOOK1 CARD11 CACYBP ATP2A2 GOLGA4 DOP1A | 8.27e-07 | 871 | 108 | 18 | int:KCNA3 |
| Interaction | UHRF2 interactions | 1.23e-05 | 200 | 108 | 8 | int:UHRF2 | |
| Interaction | PPEF2 interactions | 1.67e-05 | 29 | 108 | 4 | int:PPEF2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 5.16e-05 | 167 | 109 | 5 | chr1q25 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 7.50e-04 | 11 | 68 | 2 | 1168 | |
| GeneFamily | CTAGE family | 1.42e-03 | 15 | 68 | 2 | 907 | |
| GeneFamily | LIM domain containing | 1.42e-03 | 59 | 68 | 3 | 1218 | |
| GeneFamily | DNA helicases | 1.83e-03 | 17 | 68 | 2 | 1167 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 2.79e-03 | 21 | 68 | 2 | 980 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | ATRX KTN1 PSMD12 TUBGCP3 ITSN2 SCAPER HLTF LIMCH1 MAPK9 SNX2 | 9.77e-06 | 429 | 106 | 10 | M29 |
| Coexpression | GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN | 1.58e-05 | 197 | 106 | 7 | M5475 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | RANBP2 CDV3 SERBP1 MAP7D3 ATRX POLA1 KTN1 CEP290 CKAP5 CHD2 DICER1 FABP7 CADM1 CATSPER1 HOOK1 HECTD2 MPHOSPH10 CACYBP QKI GOLGA4 | 9.70e-08 | 989 | 107 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | RANBP2 ATRX POLA1 CEP290 CKAP5 CHD2 DICER1 CATSPER1 HECTD2 MPHOSPH10 GOLGA4 | 4.96e-07 | 311 | 107 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | MAP7D3 ATRX POLA1 KTN1 CEP290 CKAP5 FABP7 CADM1 HOOK1 MPHOSPH10 QKI GOLGA4 | 7.99e-06 | 498 | 107 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.39e-05 | 192 | 107 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RANBP2 SERBP1 ATRX POLA1 KTN1 CEP290 NUMA1 CKAP5 CHD2 HOOK1 SDF4 MPHOSPH10 QKI GOLGA4 | 7.36e-05 | 831 | 107 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CALD1 ATRX ZNF618 SYNE1 CKAP5 SP110 HECTD2 ITSN2 SCAPER TTL LIMCH1 PLEKHH2 DOP1A | 9.44e-05 | 744 | 107 | 13 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | RANBP2 EDF1 CDV3 SERBP1 KTN1 CDC42BPB FABP7 CADM1 HOOK1 DDX54 MPHOSPH10 CACYBP MRPL49 ATP2A2 DNMT3B | 1.32e-04 | 991 | 107 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.34e-04 | 298 | 107 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.75e-04 | 232 | 107 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | ATRX DNAJC8 MARK1 POLA1 ZNF618 GRK4 CEP290 CKAP5 FABP7 ACSM3 HOOK1 CCDC42 HECTD2 TTL MPHOSPH10 CACYBP QKI THRAP3 | 2.37e-04 | 1414 | 107 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.58e-04 | 328 | 107 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | ATRX DNAJC8 MARK1 POLA1 ZNF618 GRK4 CEP290 CKAP5 HOOK1 HECTD2 TTL MPHOSPH10 CACYBP QKI THRAP3 | 2.74e-04 | 1060 | 107 | 15 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 3.17e-08 | 198 | 109 | 8 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.17e-08 | 198 | 109 | 8 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | ASK452-Epithelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.30e-08 | 199 | 109 | 8 | e8778d4d2bc7e15b4c7989a93e5808a76738df46 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-07 | 176 | 109 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-07 | 182 | 109 | 7 | 9fc2f84bf70ad9a11c8a7326bd101e6f6cbcc33e | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-07 | 185 | 109 | 7 | 502361b041a036de024eb5fe378ca09fac9b67ee | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.48e-07 | 196 | 109 | 7 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.48e-07 | 196 | 109 | 7 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.67e-07 | 197 | 109 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.67e-07 | 197 | 109 | 7 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.86e-07 | 198 | 109 | 7 | 9f972f217d2c39d4c0f7d0d4227d0fffe8535b9d | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.06e-07 | 199 | 109 | 7 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.06e-07 | 199 | 109 | 7 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.27e-07 | 200 | 109 | 7 | 3d51aebf626dd4656ab4aac8a20d761b8062c42d | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.27e-07 | 200 | 109 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.77e-06 | 176 | 109 | 6 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.93e-06 | 177 | 109 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.26e-06 | 179 | 109 | 6 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.26e-06 | 179 | 109 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.60e-06 | 181 | 109 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 5.97e-06 | 183 | 109 | 6 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 5.97e-06 | 183 | 109 | 6 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | IPF-Epithelial-ATI|IPF / Disease state, Lineage and Cell class | 5.97e-06 | 183 | 109 | 6 | c0a3541c45bd0c587603521f392f42dd86c3c35b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-06 | 184 | 109 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 6.35e-06 | 185 | 109 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-06 | 186 | 109 | 6 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 6.75e-06 | 187 | 109 | 6 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-06 | 187 | 109 | 6 | 806075c2531a7f5c1da38b85ea494a3b4b5e92ec | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.96e-06 | 188 | 109 | 6 | e9cef856a96a97afac5ecafe2ee91eff0d731e01 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-06 | 191 | 109 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 7.62e-06 | 191 | 109 | 6 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-06 | 191 | 109 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-06 | 191 | 109 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.85e-06 | 192 | 109 | 6 | 8b625c22dda23c99654c82c529a1233e99e71b54 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.33e-06 | 194 | 109 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.58e-06 | 195 | 109 | 6 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|normal_Lung / Location, Cell class and cell subclass | 8.58e-06 | 195 | 109 | 6 | 569d1ebc5a5aa110a2430b096755ae35354040c4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.58e-06 | 195 | 109 | 6 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | ASK452|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.58e-06 | 195 | 109 | 6 | 7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.83e-06 | 196 | 109 | 6 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.83e-06 | 196 | 109 | 6 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.83e-06 | 196 | 109 | 6 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.09e-06 | 197 | 109 | 6 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.09e-06 | 197 | 109 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.09e-06 | 197 | 109 | 6 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|Epithelial_cells / Location, Cell class and cell subclass | 9.09e-06 | 197 | 109 | 6 | 7d19b93d6853828e2a036e37c4887edb1de4503c | |
| ToppCell | ASK440-Epithelial-Type_1|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.09e-06 | 197 | 109 | 6 | 1eda2c2504451a3d626dda5c2b2b12eeaa6bca54 | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.09e-06 | 197 | 109 | 6 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.09e-06 | 197 | 109 | 6 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.36e-06 | 198 | 109 | 6 | 5a85c286f79cde5811d2595a3397c6fb7685adee | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 9.36e-06 | 198 | 109 | 6 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 9.36e-06 | 198 | 109 | 6 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.36e-06 | 198 | 109 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 9.36e-06 | 198 | 109 | 6 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | 9.36e-06 | 198 | 109 | 6 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.63e-06 | 199 | 109 | 6 | aca81a879ef9c196bd1885eff4c63ffe6c9682b7 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 9.63e-06 | 199 | 109 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.63e-06 | 199 | 109 | 6 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 9.63e-06 | 199 | 109 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 9.63e-06 | 199 | 109 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.63e-06 | 199 | 109 | 6 | c1daa481f88d5281b6b5ea8ec8bb70cc0907d613 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 9.63e-06 | 199 | 109 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 9.63e-06 | 199 | 109 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.63e-06 | 199 | 109 | 6 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 9.63e-06 | 199 | 109 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 109 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | distal-2-Epithelial-Alveolar_Epithelial_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.91e-06 | 200 | 109 | 6 | 313ec1e53bd738a9cb48dc5b946261156f99f44b | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.91e-06 | 200 | 109 | 6 | c6f211bbadd0c9be776c58807249e06764df47dc | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 109 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | distal-3-Epithelial-Alveolar_Epithelial_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.91e-06 | 200 | 109 | 6 | ff64454a08ae8d4cc6e8f0392558460020844bbc | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT1|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.91e-06 | 200 | 109 | 6 | b746dcc94814bcbca63c71e6451a9c5f084bcfaf | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 109 | 6 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.91e-06 | 200 | 109 | 6 | 5f7e8d8b05c90a10313775f9f126eb4ab0fe4f67 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.91e-06 | 200 | 109 | 6 | ccd0edd483728279fe15d64be3a39e8636bf2eeb | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.91e-06 | 200 | 109 | 6 | cbe3e107ac16c17687d73ebb04c39d51aba1fa98 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.91e-06 | 200 | 109 | 6 | e3a80626941363bfc9d97ef906d38c97080aecb1 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT1|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.91e-06 | 200 | 109 | 6 | 3a9633f5913f12b6865fc777c84f3f3ba795a78d | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 6.18e-05 | 170 | 109 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.35e-05 | 171 | 109 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.71e-05 | 173 | 109 | 5 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.71e-05 | 173 | 109 | 5 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.89e-05 | 174 | 109 | 5 | 9f2e253694eb5860c00528fda31c305c6de8a2a1 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.47e-05 | 177 | 109 | 5 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 177 | 109 | 5 | 8f0873d348f37c823294b698043319b6608b678a | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.68e-05 | 178 | 109 | 5 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 178 | 109 | 5 | 445fb243d738a34794d66f34b92dde1f3ea6738e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 178 | 109 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | lung|World / shred on tissue and cell subclass | 7.68e-05 | 178 | 109 | 5 | 7b1e371272328d6b6c3994382d64281ffc737db2 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.88e-05 | 179 | 109 | 5 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.88e-05 | 179 | 109 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-05 | 180 | 109 | 5 | 35c73670da90cb6924e822a2426d13a675685f09 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-05 | 180 | 109 | 5 | 6327c938a4f99df9fee714e44f15ea4a4a63ae15 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.52e-05 | 182 | 109 | 5 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | B_cell_maturation-immature_B_cell|World / Lineage and Cell class | 8.52e-05 | 182 | 109 | 5 | 2c7c51ebc4125d8a33454ffee0b143579ce5e451 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.52e-05 | 182 | 109 | 5 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 8.52e-05 | 182 | 109 | 5 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.75e-05 | 183 | 109 | 5 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 8.75e-05 | 183 | 109 | 5 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-05 | 183 | 109 | 5 | 0e8fb371d8eac777451c76f41d53577f5dfb740d | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-05 | 183 | 109 | 5 | 877559962b2b073fc2a9f1b64a76e17895e40a97 | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.55e-06 | 194 | 106 | 8 | 4015_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.68e-05 | 173 | 106 | 7 | 2084_DN | |
| Drug | Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A | 3.39e-05 | 193 | 106 | 7 | 6704_DN | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; HL60; HT_HG-U133A | 3.39e-05 | 193 | 106 | 7 | 2459_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 3.62e-05 | 195 | 106 | 7 | 7254_UP | |
| Drug | estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.74e-05 | 196 | 106 | 7 | 6928_UP | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 3.86e-05 | 197 | 106 | 7 | 2117_UP | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; HL60; HG-U133A | 3.86e-05 | 197 | 106 | 7 | 1386_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | 3.99e-05 | 198 | 106 | 7 | 7384_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 3.99e-05 | 198 | 106 | 7 | 5220_DN | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.12e-05 | 199 | 106 | 7 | 6244_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; HL60; HT_HG-U133A | 4.12e-05 | 199 | 106 | 7 | 2715_DN | |
| Drug | Isocorydine (+) [475-67-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.25e-05 | 200 | 106 | 7 | 4505_DN | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.23e-04 | 28 | 102 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | VACTERL association (implicated_via_orthology) | 1.76e-04 | 6 | 102 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | Retinitis Pigmentosa | 4.75e-04 | 104 | 102 | 4 | C0035334 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 5.23e-04 | 10 | 102 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Diabetic Cardiomyopathies | 6.38e-04 | 11 | 102 | 2 | C0853897 | |
| Disease | Umbilical hernia | 6.38e-04 | 11 | 102 | 2 | HP_0001537 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 7.64e-04 | 12 | 102 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Bardet-Biedl Syndrome | 9.00e-04 | 13 | 102 | 2 | C0752166 | |
| Disease | diffuse large B-cell lymphoma | 1.05e-03 | 14 | 102 | 2 | EFO_0000403 | |
| Disease | essential hypertension (is_implicated_in) | 1.75e-03 | 18 | 102 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.72e-03 | 80 | 102 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Autism Spectrum Disorders | 3.23e-03 | 85 | 102 | 3 | C1510586 | |
| Disease | Myocardial Ischemia | 3.30e-03 | 176 | 102 | 4 | C0151744 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KIFEGKTVNDKIWQE | 76 | A8MT66 | |
| GQDIDDNWVKDRKKE | 271 | Q9BRK5 | |
| SEDWGKEEGQFQKRK | 391 | Q8NEC5 | |
| AEVWKGEVSELNKQK | 231 | Q8IX94 | |
| AEVWKGEVSELNKQK | 231 | Q86UF2 | |
| NDVRNITKKNIEEWG | 626 | Q9UBC3 | |
| KAGEVSREVWEKAGK | 81 | P28330 | |
| GEQQWKSEKQREAEL | 56 | Q15327 | |
| GQNNSVKEWEDKKVS | 561 | Q5JWR5 | |
| VRGQEDNKAWKLKAV | 436 | O76090 | |
| DLWTQGKKTEVQKRE | 71 | Q8IVJ8 | |
| IQDRSDIWAEVKKKE | 296 | Q96M95 | |
| VVNQDKSNTDKWEKD | 1386 | Q9UPY3 | |
| KAVTKDEDEWKELEQ | 76 | Q9UKY7 | |
| VESKEWKERGIGNVK | 1206 | P49792 | |
| DKKKEEQNRGKPNWE | 131 | Q96PU8 | |
| DDRKEGAVLAKKVNW | 376 | O00391 | |
| REAERKAQKEKEEWE | 391 | Q9NZM3 | |
| LDKTKNNWEDREKFE | 181 | Q9UGN5 | |
| NNWEDREKFEKVPGK | 186 | Q9UGN5 | |
| DRVKKEWEEAELQAK | 406 | Q06481 | |
| DEWKAIQNKDRAKVE | 291 | Q8NC51 | |
| LKNVSGKIWDEDNEK | 166 | Q9H4D5 | |
| MDWEERSKNGVVKDQ | 361 | P45984 | |
| QDFKEEKPQENKTWR | 591 | Q8IYF1 | |
| GFVWTAVDKEKNKEV | 1011 | Q96RG2 | |
| DDQGEDKKSPWQKRE | 866 | Q5VUB5 | |
| QVKEAGIAWDKGEKR | 556 | Q8N201 | |
| NKEITWLKEEGVKQD | 1091 | Q13439 | |
| EQNGAKIVATKEWKR | 206 | Q4FZB7 | |
| QEDVEKVKSSGDWKA | 136 | Q5U5R9 | |
| WKQKQKIDDRDSDEE | 771 | Q8TDD1 | |
| GQEARVQSWKEEEKK | 686 | Q8IY33 | |
| EDVETSKKWAAGQNK | 36 | O60869 | |
| GTIARWEKKEGDKIN | 106 | P10515 | |
| QRWEKKVGEKLSEGD | 236 | P10515 | |
| NKAWVESREKQAKGD | 211 | Q9HB71 | |
| SRDNGIKKWDLDQQE | 1521 | O75037 | |
| QAWDDVVRKEKPKED | 436 | O00566 | |
| EQVAKDLAKKEAEQW | 551 | Q96MY7 | |
| SVEQEENKWKVKVDE | 1156 | Q86UP2 | |
| EKIWEEEKRQEQEDK | 531 | A8MZA4 | |
| EKIWEEEKRQEQEDK | 506 | H0YM25 | |
| FEEKKKQREIEGQWG | 806 | Q96CW5 | |
| EGEKRWKDLKNRVVE | 346 | O00232 | |
| TENENEKRKWVGILE | 1196 | Q9Y5S2 | |
| KAWDKESEPAEEVKQ | 271 | P09884 | |
| GQIKLWEAKVEEVDR | 851 | Q8IVE3 | |
| GEEWNKAKRVAKELD | 1371 | Q9UG01 | |
| KGNTELKGKSEVEEW | 181 | Q9BY67 | |
| DWKKERNEGNEKPRA | 121 | Q8N878 | |
| LEQVKKLKERWGSNE | 26 | P16615 | |
| KKWQERKEALESVEV | 291 | Q14008 | |
| DKNWKIRKEGLDEVA | 871 | Q14008 | |
| NEFEKWQEGLKDDEK | 1636 | P46100 | |
| KKWAEEFNDETNVRG | 2096 | P46100 | |
| RTKKVGKNEAVLEWD | 526 | P40189 | |
| VDREEEWKQGKIRKE | 161 | Q8WXQ3 | |
| KKQEKWKQEPSEDEQ | 146 | O14647 | |
| KEKNAKEELIRWEEG | 1901 | O15078 | |
| KEKEAERRWKEGNFN | 451 | Q7Z7M9 | |
| EWEAKQEKIKSEEIE | 186 | Q14320 | |
| AKVVWQFRGKEDLDK | 121 | Q9Y375 | |
| GEKEEGKKVRRQWES | 151 | Q96RY5 | |
| EEREAVLQGLKKNWE | 191 | Q8TC29 | |
| ESEQKEEWDKDVARK | 446 | Q9P0L2 | |
| TKKKKGWLDQEDQEA | 661 | Q8IWC1 | |
| KAKREREWQKNFEES | 201 | O75937 | |
| KEKKSENEWTQTRQG | 46 | Q9H819 | |
| EFKRTQKNLGNWKEE | 891 | Q13753 | |
| ELEKQVWQARKEGAA | 251 | Q6ZQY3 | |
| WGKEENRKAVSDQLK | 151 | Q14527 | |
| DVGDNWRIKASNVKK | 66 | Q9UJC3 | |
| KGGKIQEDKEVEIWS | 3956 | Q8NDH2 | |
| QKWDGKETNFVREIK | 96 | O15540 | |
| EKVKWEEVDQRIKND | 391 | P32298 | |
| SWKEKEAEKREEQAP | 946 | D6RIA3 | |
| QKASRKNERKDAEGW | 251 | Q9BY12 | |
| VEKSEGQVDVEKWKF | 86 | Q92736 | |
| KDKIGEEQRKTIWVD | 1136 | Q9BXL7 | |
| EKQDRRWKKSFQGDD | 866 | Q9UPQ0 | |
| RAEELGQELKAWQEK | 1321 | Q14980 | |
| EKWEVVQKQEAEGVR | 781 | Q7Z6I6 | |
| SAEVWNENKERREKK | 421 | Q8TC56 | |
| VAEEWVTKGKDKLDQ | 66 | Q9BXD5 | |
| INAKVAEWREEGKAE | 276 | Q9Y230 | |
| AKNEIREWEAKVQQG | 446 | O60749 | |
| KFQQVDEWLKTAEEK | 3606 | Q8NF91 | |
| IWIGKDANEVEKKES | 656 | Q9Y6U3 | |
| SIDKKRKEFDTNGWQ | 571 | Q9P0U3 | |
| EFEVEGKGRNAKNWK | 501 | Q9HB58 | |
| RKVEGDIWALQKDVE | 111 | Q13405 | |
| KQGDEEEKWAEKAVD | 21 | Q15797 | |
| GEKVEQKIEGKWVNE | 406 | Q05682 | |
| EGIQKKETAKINWDQ | 201 | O75891 | |
| AKDVLDQWTDKEKAG | 61 | Q53FZ2 | |
| SDQKLWEEVGEEAKK | 401 | Q14028 | |
| KSENWGNFIAKEEEK | 91 | Q7Z3I7 | |
| WKQKIVQAGDKDLDG | 51 | Q6KCM7 | |
| KNQEEEKSGKWEGLV | 461 | Q9Y2W1 | |
| IQEVIWQGEAKEEKK | 71 | Q5T7W0 | |
| WQGEAKEEKKAVSKD | 76 | Q5T7W0 | |
| EDQWLEKKVQGNKDH | 636 | O15394 | |
| WAQKGDRESKKADTN | 601 | Q9UQP3 | |
| KVAARVKAVDGDEQW | 161 | Q96ES7 | |
| QDNSWIKKRPEEEKD | 41 | O95171 | |
| WKKVAEKEELEQGSR | 146 | Q9H788 | |
| NWDKLVGEIKEEEKN | 286 | Q9Y2Z0 | |
| WRKEEKKLQEGNEVD | 516 | A0A1B0GTU1 | |
| REEQSLAEWQGKVKE | 166 | Q9Y577 | |
| TQLEQGKETWREEKK | 51 | P52736 | |
| GKQKKKERCWEDDDN | 516 | Q8N3Z6 | |
| EKEEAAKKWLEEQER | 96 | Q15695 | |
| NRKKEDGEGNVWIAK | 136 | Q8NG68 | |
| ALEEKWKNDRQQKGE | 116 | Q5THJ4 |